(Q72281178)
Statements
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days (English)
Thompson DS
Greco A
Miller AA
Srinivas NR
Igwenezue KB
Hainsworth JD
Schacter LP
Kaul S
Barbhaiya RH